Molecular Biomarkers of Tumors

In the fast advancing era of oncology from purely histopathological tumor classification to an integrated framework incorporating molecular genetics. Understanding the genetic makeup of tumors is essential for accurate diagnostics, prognostics, and therapeutic decision-making. With breakthroughs in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Formaat: Online
Taal:Engels
Gepubliceerd in: MDPI - Multidisciplinary Digital Publishing Institute 2026
Onderwerpen:
Online toegang:ONIX_20260416T142754_9783725852659_15
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
_version_ 1869528662561259520
collection Directory of Open Access Books
description In the fast advancing era of oncology from purely histopathological tumor classification to an integrated framework incorporating molecular genetics. Understanding the genetic makeup of tumors is essential for accurate diagnostics, prognostics, and therapeutic decision-making. With breakthroughs in sequencing technologies and genomic profiling, novel molecular biomarkers are being discovered—there is a demand to showcase and disseminate these advances. Translation of bench-side discoveries of genetic markers into routine clinical use is demanding in creating dynamic scientific discourse and collaborative networks. The Special Issue of the “Molecular Biomarkers of Tumors: Advancing Genetic Studies” in Biomedicine provides not only timely and thoughtful reviews on Prostate Cancer, Glioma and Bladder Cancer, but also state-of-the-art research updates on Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Renal Carcinoma as well as Chronic Myelomonocytic Leukemia. These research articles span discovery to clinical translation—to foster collaboration and propel precision oncology. The content of this Special Issue is to target cancer researchers and molecular biologists; clinical oncologists, pathologists, and laboratory medicine professionals, translational scientists and bioinformaticians working on the functional and clinical integration of genetic data. Precision medicine advocates and healthcare decision-makers interested in harnessing genetic insights for improved patient care; as well as interdisciplinary teams seeking to bridge scientific discovery with real-world clinical application.
format Online
id doab-20.500.12854ir-174710
institution Directory of Open Access Books
language eng
publishDate 2026
publishDateRange 2026
publishDateSort 2026
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1747102026-04-16T16:02:51Z Molecular Biomarkers of Tumors Wei, Sainan Di, Jing Molecular Biomarker Prognosis Genetic Mutation Fluorescence In Situ Hybridization Breast Cancer Prostate Cancer Lung Cancer CMML Microsatellite Instability thema EDItEUR::M Medicine and Nursing In the fast advancing era of oncology from purely histopathological tumor classification to an integrated framework incorporating molecular genetics. Understanding the genetic makeup of tumors is essential for accurate diagnostics, prognostics, and therapeutic decision-making. With breakthroughs in sequencing technologies and genomic profiling, novel molecular biomarkers are being discovered—there is a demand to showcase and disseminate these advances. Translation of bench-side discoveries of genetic markers into routine clinical use is demanding in creating dynamic scientific discourse and collaborative networks. The Special Issue of the “Molecular Biomarkers of Tumors: Advancing Genetic Studies” in Biomedicine provides not only timely and thoughtful reviews on Prostate Cancer, Glioma and Bladder Cancer, but also state-of-the-art research updates on Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Renal Carcinoma as well as Chronic Myelomonocytic Leukemia. These research articles span discovery to clinical translation—to foster collaboration and propel precision oncology. The content of this Special Issue is to target cancer researchers and molecular biologists; clinical oncologists, pathologists, and laboratory medicine professionals, translational scientists and bioinformaticians working on the functional and clinical integration of genetic data. Precision medicine advocates and healthcare decision-makers interested in harnessing genetic insights for improved patient care; as well as interdisciplinary teams seeking to bridge scientific discovery with real-world clinical application. 2026-04-16T16:02:48Z 2026-04-16T16:02:48Z 2025 book ONIX_20260416T142754_9783725852659_15 9783725852659 9783725852666 https://directory.doabooks.org/handle/20.500.12854/174710 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/ https://mdpi.com/books/pdfview/book/11585 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-5266-6 10.3390/books978-3-7258-5266-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725852659 9783725852666 218 CH open access
spellingShingle Molecular Biomarker
Prognosis
Genetic Mutation
Fluorescence In Situ Hybridization
Breast Cancer
Prostate Cancer
Lung Cancer
CMML
Microsatellite Instability
thema EDItEUR::M Medicine and Nursing
Molecular Biomarkers of Tumors
title Molecular Biomarkers of Tumors
title_full Molecular Biomarkers of Tumors
title_fullStr Molecular Biomarkers of Tumors
title_full_unstemmed Molecular Biomarkers of Tumors
title_short Molecular Biomarkers of Tumors
title_sort molecular biomarkers of tumors
topic Molecular Biomarker
Prognosis
Genetic Mutation
Fluorescence In Situ Hybridization
Breast Cancer
Prostate Cancer
Lung Cancer
CMML
Microsatellite Instability
thema EDItEUR::M Medicine and Nursing
topic_facet Molecular Biomarker
Prognosis
Genetic Mutation
Fluorescence In Situ Hybridization
Breast Cancer
Prostate Cancer
Lung Cancer
CMML
Microsatellite Instability
thema EDItEUR::M Medicine and Nursing
url ONIX_20260416T142754_9783725852659_15